-
Mashup Score: 0
In this issue of the Journal of the American Heart Association (JAHA), Zhang and colleagues1 have reported that the intake of omega‐3 (ω3) polyunsaturated fatty acids (PUFAs), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) are associated with a reduction in blood pressure (BP) and identified the optimal dose of 2 to 3 g/d. Although these findings are not entirely novel, they are…
Categories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases - 2 year(s) ago
Prospective observational studies support the use of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; however, randomised controlled trials, have often reported neutral findings. There is a long history of debate about the potential harmful effects of a high intake of omega-6 PUFAs, although this idea is not supported by…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 4Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases - 2 year(s) ago
Prospective observational studies support the use of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; however, randomised controlled trials, have often reported neutral findings. There is a long history of debate about the potential harmful effects of a high intake of omega-6 PUFAs, although this idea is not supported by…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 3Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases - 2 year(s) ago
Prospective observational studies support the use of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; however, randomised controlled trials, have often reported neutral findings. There is a long history of debate about the potential harmful effects of a high intake of omega-6 PUFAs, although this idea is not supported by…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 7179. Lipids: Triglycerides – Polyunsaturated Fatty Acids, Omega-3 Fatty Acids, Eicosapentaenoic acid – Mechanisms of Action with Dr. Ty Gluckman - 2 year(s) ago
The CardioNerds Lipid Series continues with Polyunsaturated Fatty Acids, Omega-3 Fatty Acids, Eicosapentaenoic acid with Dr. Ty Gluckman
Source: CardionerdsCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 2Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases - 2 year(s) ago
Prospective observational studies support the use of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; however, randomised controlled trials, have often reported neutral findings. There is a long history of debate about the potential harmful effects of a high intake of omega-6 PUFAs, although this idea is not supported by…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 5Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases - 3 year(s) ago
Prospective observational studies support the use of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; however, randomised controlled trials, have often reported neutral findings. There is a long history of debate about the potential harmful effects of a high intake of omega-6 PUFAs, although this idea is not supported by…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 1Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases - 3 year(s) ago
Prospective observational studies support the use of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; however, randomised controlled trials, have often reported neutral findings. There is a long history of debate about the potential harmful effects of a high intake of omega-6 PUFAs, although this idea is not supported by…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 0Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases - 3 year(s) ago
Prospective observational studies support the use of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; however, randomised controlled trials, have often reported neutral findings. There is a long history of debate about the potential harmful effects of a high intake of omega-6 PUFAs, although this idea is not supported by…
Categories: Endocrinology, Latest HeadlinesTweet
-
Mashup Score: 8Intake and metabolism of omega-3 and omega-6 polyunsaturated fatty acids: nutritional implications for cardiometabolic diseases - 3 year(s) ago
Prospective observational studies support the use of long-chain omega-3 polyunsaturated fatty acids (PUFAs) in the primary prevention of atherosclerotic cardiovascular disease; however, randomised controlled trials, have often reported neutral findings. There is a long history of debate about the potential harmful effects of a high intake of omega-6 PUFAs, although this idea is not supported by…
Categories: Endocrinology, Latest HeadlinesTweet
Could the blood pressure–lowering effects of omega‐3 #PUFAs explain their role in modifying #cardiovascular risk? @DrMarcJGeorge1 @ajaya2000 #AHAJournals https://t.co/0Arzeb2obj